216 related articles for article (PubMed ID: 32847850)
1. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
Salamango DJ; McCann JL; Demir Ö; Becker JT; Wang J; Lingappa JR; Temiz NA; Brown WL; Amaro RE; Harris RS
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847850
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulators.
Salamango DJ; Ikeda T; Moghadasi SA; Wang J; McCann JL; Serebrenik AA; Ebrahimi D; Jarvis MC; Brown WL; Harris RS
Cell Rep; 2019 Oct; 29(5):1057-1065.e4. PubMed ID: 31665623
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest.
Marelli S; Williamson JC; Protasio AV; Naamati A; Greenwood EJ; Deane JE; Lehner PJ; Matheson NJ
Elife; 2020 Apr; 9():. PubMed ID: 32292164
[TBL] [Abstract][Full Text] [Related]
4. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary Conservation of PP2A Antagonism and G2/M Cell Cycle Arrest in Maedi-Visna Virus Vif.
Luperchio AM; Jónsson SR; Salamango DJ
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016323
[TBL] [Abstract][Full Text] [Related]
6. Demystifying Cell Cycle Arrest by HIV-1 Vif.
Salamango DJ; Harris RS
Trends Microbiol; 2021 May; 29(5):381-384. PubMed ID: 33478820
[TBL] [Abstract][Full Text] [Related]
7. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
[TBL] [Abstract][Full Text] [Related]
8. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
Zhang W; Du J; Evans SL; Yu Y; Yu XF
Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
[TBL] [Abstract][Full Text] [Related]
9. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
[TBL] [Abstract][Full Text] [Related]
10. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
Pery E; Rajendran KS; Brazier AJ; Gabuzda D
J Virol; 2009 Mar; 83(5):2374-81. PubMed ID: 19109396
[TBL] [Abstract][Full Text] [Related]
11. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
Ai Y; Ma J
Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
[TBL] [Abstract][Full Text] [Related]
12. Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.
Zhao K; Du J; Rui Y; Zheng W; Kang J; Hou J; Wang K; Zhang W; Simon VA; Yu XF
Cell Cycle; 2015; 14(6):838-47. PubMed ID: 25590520
[TBL] [Abstract][Full Text] [Related]
13. Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.
Letko M; Booiman T; Kootstra N; Simon V; Ooms M
Cell Rep; 2015 Dec; 13(9):1789-99. PubMed ID: 26628364
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.
Evans EL; Becker JT; Fricke SL; Patel K; Sherer NM
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321323
[TBL] [Abstract][Full Text] [Related]
15. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.
Siu KK; Sultana A; Azimi FC; Lee JE
Nat Commun; 2013; 4():2593. PubMed ID: 24185281
[TBL] [Abstract][Full Text] [Related]
17. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.
Chen G; He Z; Wang T; Xu R; Yu XF
J Virol; 2009 Sep; 83(17):8674-82. PubMed ID: 19535450
[TBL] [Abstract][Full Text] [Related]
18. Critical role of PP2A-B56 family protein degradation in HIV-1 Vif mediated G2 cell cycle arrest.
Nagata K; Shindo K; Matsui Y; Shirakawa K; Takaori-Kondo A
Biochem Biophys Res Commun; 2020 Jun; 527(1):257-263. PubMed ID: 32446377
[TBL] [Abstract][Full Text] [Related]
19. Hydrodynamic and functional analysis of HIV-1 Vif oligomerization.
Techtmann SM; Ghirlando R; Kao S; Strebel K; Maynard EL
Biochemistry; 2012 Mar; 51(10):2078-86. PubMed ID: 22369580
[TBL] [Abstract][Full Text] [Related]
20. Genetic and functional characterization of HIV-1 Vif on APOBEC3G degradation: First report of emergence of B/C recombinants from North India.
Ronsard L; Raja R; Panwar V; Saini S; Mohankumar K; Sridharan S; Padmapriya R; Chaudhuri S; Ramachandran VG; Banerjea AC
Sci Rep; 2015 Oct; 5():15438. PubMed ID: 26494109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
